Compare BBDC & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBDC | STAA |
|---|---|---|
| Founded | 2006 | 1982 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | Diversified Financial Services | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 928.8M | 867.9M |
| IPO Year | 2006 | 1995 |
| Metric | BBDC | STAA |
|---|---|---|
| Price | $8.91 | $26.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $9.56 | ★ $22.81 |
| AVG Volume (30 Days) | 616.6K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | ★ 11.67% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | $7.95 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.97 | $15.59 |
| 52 Week High | $9.92 | $30.81 |
| Indicator | BBDC | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 51.66 | 61.78 |
| Support Level | $8.72 | $26.54 |
| Resistance Level | $9.08 | $27.27 |
| Average True Range (ATR) | 0.18 | 1.07 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 28.23 | 63.16 |
Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. It employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.